Agios Pharmaceuticals

Filed a patent for "compounds and methods useful for stabilizing phenylalanine hydroxylase mutations" on Wed, August 30, 2023

Filed a patent for "synthesis of pyruvate kinase activators" on Wed, July 5, 2023

Filed a patent for "crystalline forms of 2-((1h-pyrazol-3-yl)methyl)-6-((6-aminopyridin-2-yl)methyl)-4-methyl-4,6-dihydro-5h-thiazolo[5',4':4,5]pyrrolo[2,3-d]pyridazin-5-one" on Mon, May 15, 2023

Filed a patent for "bcat2 inhibitors" on Wed, May 17, 2023

Filed a patent for "therapy for treating malignancies" on Tue, December 19, 2023

Filed a patent for "cocrystals, pharmaceutical compositions thereof, and methods of treatment involving same" on Thu, October 17, 2024

Filed a patent for "therapeutically active compounds and their methods of use" on Thu, October 10, 2024

Filed a patent for "pyruvate kinase activators for use in therapy" on Thu, August 22, 2024

Filed a patent for "compounds for treating mds-associated anemias and other conditions" on Thu, June 30, 2022

Filed a patent for "use of a dhodh inhibitor compound in combination cancer therapy" on Thu, September 14, 2023

Filed a patent for "use of a dhodh inhibitor compound in combination cancer therapy" on Thu, September 14, 2023

Filed a patent for "pyruvate kinase activators for use in treating blood disorders" on Thu, July 20, 2023

Filed a patent for "compounds and methods useful for stabilizing phenylalanine hydroxylase mutations" on Thu, November 16, 2023

Filed a patent for "pharmaceutical formulation" on Thu, October 26, 2023

Filed a patent for "therapy for treating malignancies" on Thu, September 7, 2023

Filed a patent for "methods of use for trisubstituted benzotriazole derivatives" on Thu, May 9, 2024

Filed a patent for "compounds and methods useful for stabilizing phenylalanine hydroxylase mutations" on Thu, October 26, 2023

Filed a patent for "methods for titrating mitapivat" on Mon, October 30, 2023

Filed a patent for "pyruvate kinase activators for use in treating blood disorders" on Thu, December 15, 2022

Filed a patent for "bcat2 inhibitors" on Fri, July 8, 2022